Virani, Salim S; Koschinsky, Marlys L; Maher, Lisa; Mehta, Anurag; Orringer, Carl E; Santos Filho, Raul Dias dos 
; Shapiro, Michael D; Saseen, Joseph J
Source: Progress in cardiovascular diseases. Unidade: FM
Subjects: LIPOPROTEÍNAS, TOMADA DE DECISÃO, PRÁTICA PROFISSIONAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIRANI, Salim S et al. Global think tank on the clinical considerations and management of lipoprotein(a): The top questions and answers regarding what clinicians need to know. Progress in cardiovascular diseases, v. 73, p. 32-40, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.pcad.2022.01.002. Acesso em: 31 maio 2024.APA
Virani, S. S., Koschinsky, M. L., Maher, L., Mehta, A., Orringer, C. E., Santos Filho, R. D. dos, et al. (2022). Global think tank on the clinical considerations and management of lipoprotein(a): The top questions and answers regarding what clinicians need to know. Progress in cardiovascular diseases, 73, 32-40. doi:10.1016/j.pcad.2022.01.002NLM
Virani SS, Koschinsky ML, Maher L, Mehta A, Orringer CE, Santos Filho RD dos, Shapiro MD, Saseen JJ. Global think tank on the clinical considerations and management of lipoprotein(a): The top questions and answers regarding what clinicians need to know [Internet]. Progress in cardiovascular diseases. 2022 ; 73 32-40.[citado 2024 maio 31 ] Available from: https://doi.org/10.1016/j.pcad.2022.01.002Vancouver
Virani SS, Koschinsky ML, Maher L, Mehta A, Orringer CE, Santos Filho RD dos, Shapiro MD, Saseen JJ. Global think tank on the clinical considerations and management of lipoprotein(a): The top questions and answers regarding what clinicians need to know [Internet]. Progress in cardiovascular diseases. 2022 ; 73 32-40.[citado 2024 maio 31 ] Available from: https://doi.org/10.1016/j.pcad.2022.01.002
